Reports of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID)

Statement by the European Society of Gene Therapy (ESGT)

American Society of Gene Therapy Responds to a Second Case of Leukemia Seen in a Clinical Trial of Gene Therapy for Immune Deficiency

The French Medicine Agency (AFSSAPS) Statement Regarding a second serious adverse event in Clinical Gene Therapy Trial

SNFP37 somatic gene therapy
Gene Therapy adverse event in Paris